SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-022799
Filing Date
2020-11-05
Accepted
2020-11-05 16:32:54
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20200930_10q.htm   iXBRL 10-Q 1685906
2 EXHIBIT 10.1 ex_209689.htm EX-10.1 144140
3 EXHIBIT 10.3 ex_209690.htm EX-10.3 159970
9 EXHIBIT 31.1 ex_209695.htm EX-31.1 8718
10 EXHIBIT 31.2 ex_209696.htm EX-31.2 8762
11 EXHIBIT 32.1 ex_209697.htm EX-32.1 6749
  Complete submission text file 0001437749-20-022799.txt   6659470

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acrx-20200930.xsd EX-101.SCH 55654
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20200930_cal.xml EX-101.CAL 42692
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20200930_def.xml EX-101.DEF 331139
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20200930_lab.xml EX-101.LAB 301748
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20200930_pre.xml EX-101.PRE 356245
12 EXTRACTED XBRL INSTANCE DOCUMENT acrx20200930_10q_htm.xml XML 1046851
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 201291005
SIC: 2834 Pharmaceutical Preparations